Home/Filings/4/0001179110-12-007022
4//SEC Filing

Tillman Jill 4

Accession 0001179110-12-007022

CIK 0001156295other

Filed

Apr 19, 8:00 PM ET

Accepted

Apr 20, 4:31 PM ET

Size

15.5 KB

Accession

0001179110-12-007022

Insider Transaction Report

Form 4
Period: 2012-04-20
Tillman Jill
Director
Transactions
  • Disposition to Issuer

    Common Stock

    2012-04-2023,6090 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2012-04-2015,0000 total
    Exercise: $1.25Exp: 2013-11-21Common Stock (15,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2012-04-2015,0000 total
    Exercise: $3.86Exp: 2015-11-17Common Stock (15,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2012-04-203,7500 total
    Exercise: $2.73Exp: 2016-11-16Common Stock (3,750 underlying)
  • Disposition to Issuer

    Stock Options (Right to Buy)

    2012-04-2011,2500 total
    Exercise: $2.73Exp: 2016-11-16Common Stock (11,250 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2012-04-2015,0000 total
    Exercise: $3.00Exp: 2014-11-18Common Stock (15,000 underlying)
Footnotes (4)
  • [F1]Pursuant to the Agreement and Plan of Merger dated as of February 12, 2012, as amended by Amendment No. 1 to Agreement and Plan of Merger dated as of February 27, 2012, among SeraCare Life Sciences, Inc., Project Plasma Holdings Corporation and Project Plasma Merger Corp. (the "Merger Agreement"), each share of SeraCare Life Sciences, Inc.'s common stock was exchanged for $4.00 in cash, without interest and less any applicable withholding taxes.
  • [F2]Pursuant to its terms, the stock option accelerated and became fully vested as of the closing of the merger.
  • [F3]This stock option is fully vested.
  • [F4]Pursuant to the Merger Agreement, each stock option was cancelled in the merger in exchange for the right to receive an amount in cash, without interest, equal to the product of the number of shares issuable upon the exercise of such stock option and $4.00 minus the exercise price of such stock option, less any applicable withholding taxes.

Issuer

SERACARE LIFE SCIENCES INC

CIK 0001156295

Entity typeother

Related Parties

1
  • filerCIK 0001392124

Filing Metadata

Form type
4
Filed
Apr 19, 8:00 PM ET
Accepted
Apr 20, 4:31 PM ET
Size
15.5 KB